Imagabalin
From Infogalactic: the planetary knowledge core
Systematic (IUPAC) name | |
---|---|
(3S,5R)-3-amino-5-methyloctanoic acid
|
|
Identifiers | |
CAS Number | 610300-07-7 610300-00-0 (hydrochloride) |
ATC code | None |
PubChem | CID: 10236037 |
ChemSpider | 8411525 |
Synonyms | PD-0332334; PD-332,334 |
Chemical data | |
Formula | C9H19NO2 |
Molecular mass | 173.253 g/mol |
|
|
|
Imagabalin (INN, USAN; PD-332,334) is a drug which acts as a ligand for the α2δ subunit of the voltage-dependent calcium channel,[1] with some selectivity for the α2δ1 subunit over α2δ2.[2] Under development by Pfizer as a pharmaceutical medication, it has demonstrated preclinical efficacy of anxiolytic, analgesic, hypnotic, and anticonvulsant-like activity and is currently in phase III clinical trials for the treatment of generalized anxiety disorder.[2][3]
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Amino acids
- Anxiolytics
- Calcium channel blockers
- GABA analogues
- Pfizer products
- Nervous system drug stubs